CoChat

Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease

Open access
Whitehead, Garry, Regan, Philip, Whitcomb, Daniel J., Cho, Kwangwook · 2017 · Neuropharmacology
Cited by 65

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

ABSTRACT &agr;‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors (AMPARs) are the primary conduits of excitatory synaptic transmission. AMPARs are predominantly Ca2+‐impermeable in the matured excitatory synapse, except under certain circumstances. Growing evidence implicates the Ca2+ permeability of AMPARs in the regulation of long‐term synaptic plasticity and in the pathophysiology of several neurological disorders. Therefore, the Ca2+ conductance of AMPARs may have both physiological and pathological roles at synapses. However, our understanding of the role of Ca2+ permeable AMPARs (CP‐AMPARs) in Alzheimer's disease is limited. Here we discuss insights into the potential CP‐AMPAR mediated pathophysiology of Alzheimer's disease, including: 1. Ca2+‐mediated aberrant regulation of synapse weakening mechanisms, and 2. neuronal network dysfunction in the brain. Consideration of CP‐AMPARs as primary drivers of pathophysiology could help in understanding synaptopathologies, and highlights the potential of CP‐AMPARs as therapeutic targets in Alzheimer's disease. This article is part of the Special Issue entitled ‘Ionotropic glutamate receptors’.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2016.08.022

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 65

Metadata

Authors
Whitehead, G., Regan, P., Whitcomb, D. J., & Cho, K.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2017-01
Volume
112
Issue
Pt A
Pages
221-227
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2515085049
Cited by
65
References
25
FWCI
2.44
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neuropharm.2016.08.022
The paper
Whitehead, G., Regan, P., Whitcomb, D. J., & Cho, K. (2017). Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2016.08.022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.